Xilio Therapeutics, Inc. (XLO)
8.81
+1.05
(+13.53%)
USD |
NASDAQ |
May 14, 16:00
8.81
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics EPS Diluted (Quarterly) : -0.5829 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Verastem, Inc. | -0.3723 |
| Sensei Biotherapeutics, Inc. | -3.622 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.529M |
| Revenue (Quarterly) | 12.65M |
| Total Expenses (Quarterly) | 22.18M |
| Enterprise Value | -92.75M |
| Gross Profit Margin (Quarterly) | 97.28% |
| Profit Margin (Quarterly) | -75.34% |
| Earnings Yield | -41.51% |
| Normalized Earnings Yield | -44.37 |